4-Oxofenretinide

CAS No. 865536-65-8

4-Oxofenretinide( 4-Oxo-4-HPR | 4-Oxo Fenretinide | 4-Keto-4-HPR )

Catalog No. M17628 CAS No. 865536-65-8

4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 92 In Stock
2MG 48 In Stock
5MG 68 In Stock
10MG 109 In Stock
25MG 195 In Stock
50MG 286 In Stock
100MG 517 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Oxofenretinide
  • Note
    Research use only, not for human use.
  • Brief Description
    4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis.
  • Description
    4-Oxo-4-HPR is an inhibitor of tubulin polymerization, inducing marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. It is also a fenretinide metabolite.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    4-Oxo-4-HPR | 4-Oxo Fenretinide | 4-Keto-4-HPR
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    cell cycle arrest and apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    865536-65-8
  • Formula Weight
    405.53
  • Molecular Formula
    C26H31NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=C(C(CCC1=O)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)Nc1ccc(cc1)O)/C)/C
  • Chemical Name
    (2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-3-oxocyclohexen-1-yl)nona-2,4,6,8-tetraenamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Villani MG,et al. Cancer Res. 2006 Mar 15;66(6):3238-47.
molnova catalog
related products
  • Alprostadil

    Prostaglandin E1 (Alprostadil) is a prostaglandin, which is used in the treatment of erectile dysfunction and has vasodilatory properties.

  • EP2 receptor antagon...

    EP2 receptor antagonist-2 (CID891729) is a compound that blocks EP2 receptor activation by PGE2 and reduces lactate dehydrogenase (LDH) release induced by N-methyl-D-aspartate (NMDA).

  • Omidenepag

    Omidenepag (UR-7276) is a selective and potent prostaglandin E2 receptor 2 (EP2) agonist and a novel topical ocular hypotensive agent.Omidenepag is used in the study of glaucoma and hypertension.